Balyasny Asset Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-79,496
| Closed | -$308K | – | 2245 |
|
|
2024
Q4 | $308K | Buy |
+79,496
| New | +$308K | ﹤0.01% | 1618 |
|
|
2019
Q1 | – | Sell |
-45,690
| Closed | -$2.71M | – | 1402 |
|
|
2018
Q4 | $2.71M | Sell |
45,690
-29,414
| -39% | -$1.75M | 0.02% | 558 |
|
|
2018
Q3 | $10.5M | Buy |
75,104
+29,266
| +64% | +$4.11M | 0.05% | 396 |
|
|
2018
Q2 | $5.63M | Buy |
45,838
+7,329
| +19% | +$900K | 0.03% | 521 |
|
|
2018
Q1 | $3.44M | Buy |
+38,509
| New | +$3.44M | 0.01% | 679 |
|
|
2016
Q4 | – | Sell |
-40,002
| Closed | -$1.59M | – | 1232 |
|
|
2016
Q3 | $1.59M | Sell |
40,002
-21,423
| -35% | -$851K | 0.01% | 630 |
|
|
2016
Q2 | $4.42M | Buy |
61,425
+57,258
| +1,374% | +$4.12M | 0.03% | 430 |
|
|
2016
Q1 | $334K | Buy |
4,167
+400
| +11% | +$32.1K | ﹤0.01% | 784 |
|
|
2015
Q4 | $284K | Sell |
3,767
-262
| -7% | -$19.8K | ﹤0.01% | 850 |
|
|
2015
Q3 | $1.55M | Buy |
+4,029
| New | +$1.55M | 0.01% | 543 |
|